Atrium Therapeutics, Inc.
RNA
$12.69
$0.373.00%
NASDAQ
| 12/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | -- | |||
| Total Receivables | 100.00K | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | 1.54M | 483.00K | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | 1.21M | -- | |||
| Total Current Assets | 2.85M | 483.00K | |||
|
|
|||||
| Total Current Assets | 2.85M | 483.00K | |||
| Net Property, Plant & Equipment | 5.51M | 6.70M | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | -- | -- | |||
| Total Assets | 8.35M | 7.19M | |||
|
|
|||||
| Total Accounts Payable | 4.40M | 532.00K | |||
| Total Accrued Expenses | 8.69M | 1.44M | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | 3.67M | 3.84M | |||
| Total Finance Division Other Current Liabilities | 25.04M | 20.99M | |||
| Total Other Current Liabilities | 25.04M | 20.99M | |||
| Total Current Liabilities | 41.80M | 26.80M | |||
|
|
|||||
| Total Current Liabilities | 41.80M | 26.80M | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | -- | 2.96M | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | 29.27M | 38.54M | |||
| Total Liabilities | 71.07M | 68.29M | |||
|
|
|||||
| Common Stock & APIC | -62.71M | -61.11M | |||
| Retained Earnings | -- | -- | |||
| Treasury Stock & Other | -- | -- | |||
| Total Common Equity | -62.71M | -61.11M | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | -- | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | -- | -- | |||
|
|
|||||
| Total Common Equity | -62.71M | -61.11M | |||
| Total Preferred Equity | -- | -- | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | -62.71M | -61.11M | |||
|
|
|||||